ToxPlus Consulting

Executive Summary

ToxPlus Consulting is a San Diego-based private firm specializing in nonclinical drug development services, including toxicology research, safety assessments, and regulatory compliance. Founded in 2005, the company has established itself as a trusted partner for pharmaceutical and biotech companies seeking accurate, reliable data to advance their drug candidates through preclinical stages. With expertise spanning small molecules and biologics, ToxPlus offers cutting-edge toxicology support that helps clients navigate complex FDA and global regulatory requirements. The firm's focus on quality and scientific rigor positions it as a key player in the outsourced drug development space, particularly as the demand for specialized toxicology services continues to grow alongside the expansion of novel therapeutic modalities. ToxPlus's long-standing presence in the industry and its commitment to client success underscore its reputation as a reliable partner for drug developers worldwide.

Upcoming Catalysts (preview)

• Q3 2026Strategic partnership with a top-20 pharmaceutical company for integrated toxicology services65% success
• Q4 2026Expansion of biologics safety testing capabilities through new in vitro assays55% success
• Q2 2026FDA issuance of new guidance on nonclinical testing for combination products75% success